bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting Read more about bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
bluebird bio to Present Clinical Data on Lenti-D in CALD in Plenary Session at AAN 2016 Annual Meeting Read more about bluebird bio to Present Clinical Data on Lenti-D in CALD in Plenary Session at AAN 2016 Annual Meeting
bluebird bio to Present at Three Upcoming Investor Conferences Read more about bluebird bio to Present at Three Upcoming Investor Conferences
bluebird bio Announces Transition of Chief Financial Officer Read more about bluebird bio Announces Transition of Chief Financial Officer
bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress Read more about bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress
bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma Read more about bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference Read more about bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference
bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting Read more about bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting
bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting Read more about bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting
bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting Read more about bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting